Aprea Therapeutics (APRE.Q) today announced positive results from its Phase 2 trial evaluating eprenetapopt with azacitidine for post-transplant maintenance therapy in patients with TP53 mutant MDS and AML. “The…
cancer
Bionano Genomics (BNGO.Q) has released a summary of results obtained by the University Hospitals Leuven, Belgium utilizing Saphyr® System, the Company’s Optical Genome Mapping (OGM) platform. The work completed…
Bionano Genomics (BNGO.Q) announced today that optical genome mapping (OGM), utilizing the Company’s Saphyr System, has revealed new insights and prognostic capabilities compared to traditional cytogenetics techniques in several…
CNS Pharmaceuticals (CNSP.Q), the company that licenses the drug candidate Berubicin to WPD Pharmaceuticals, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation…
iBio Inc. (IBIO.NYSE) announced yesterday that it has added three anti-cancer targets to its pipeline of therapeutic candidates. This development establishes the Company’s new drug discovery capabilities announced just…
Advaxis (ADXS.Q), a clinical-stage biotechnology company, and Biosight, a privately held pharmaceutical development company developing innovative therapeutics for hematological malignancies and disorders, announced today that the companies have entered…
Aravive (ARAV.Q), a clinical-stage oncology company developing innovative therapeutics to treat life-threatening diseases, announced positive initial results today from the Phase 1b portion of its Phase 1b/2 study of…
AnPac Bio-Medical (ANPC.Q) announced today that it has been granted its first disease treatment patent by the United States Patent and Trademark Office. Additionally, the Company also announced that…
Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
Perimeter Medical Imaging AI (PINK.V) announced that the US Food and Drug Administration (FDA) has granted them a Breakthrough Device Designation for their Optical Coherence Tomography (OCT) Imaging System…